Medication info
Amarong (Glimepiride)

Amarong (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Kips Biopharma Co., Ltd.
Appearance
Green oblong tablet
Packaging
30 tablets/bottle, 200 tablets/bottle
Approval status
Active

MFDS item code 200404852 · Notified 2004.11.12 · Insurance code 693200080

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow whole without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received drug therapy, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the procedure described under Initial dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the efficacy and duration of action of the previously administered medicine. 4) Dose monitoring While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Initiate insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dose adjustment is required periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. In combination therapy with this medicine and metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control.

Ingredients

Manufacturer
Kips Biopharma Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

  • Blood sugar control impairment in patients with type 2 diabetes
View approved original text

This medication is used to help control blood sugar levels in patients with type 2 diabetes. It can be administered alone or in combination therapy when blood sugar is not adequately controlled alongside diet and exercise. For example, it can be used with insulin if oral antihyperglycemic medications alone are insufficient. Additionally, in cases where sufficient blood sugar control is not achievable with sulfonylurea drugs or metformin monotherapy, it can be combined with metformin to enhance blood sugar control. These treatment methods effectively aid in the management of patients' blood sugar levels.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow whole without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received drug therapy, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the procedure described under Initial dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the efficacy and duration of action of the previously administered medicine. 4) Dose monitoring While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Initiate insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dose adjustment is required periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. In combination therapy with this medicine and metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or in a comatose state. It should also not be administered to patients who are allergic to this drug or its components, or who have severe liver or kidney dysfunction. Women who are pregnant or breastfeeding should refrain from taking this medication, and insulin therapy is recommended for patients with severe infections or those undergoing surgery or with severe trauma. Patients with gastrointestinal disorders may have issues with food absorption, leading to a risk of hypoglycemia, so care must be taken. Additionally, this medication is not suitable for patients with genetic lactose intolerance. During the first week of treatment, the risk of hypoglycemia is high, so blood sugar levels should be checked frequently, especially in elderly patients, those with malnutrition, irregular meals, alcohol consumers, and patients with weakened kidney or liver function. Careful management is also required in cases where there are other endocrine disorders, excessive use of medications, or when taking other medications that may interact with this drug. This medication contains the dye Yellow No. 4, so individuals allergic to this component should be cautious. Hypoglycemia could occur while taking this medication, with symptoms including headaches, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and in severe cases, coma. Visual disturbances or gastrointestinal symptoms, liver function abnormalities, blood anomalies, and allergic reactions may occur, so any abnormal symptoms should prompt immediate consultation with a doctor. Severe hypoglycemia or serious allergic reactions can be life-threatening; therefore, urgent measures are necessary. It is crucial to take this medication regularly and to adhere to diet and exercise regimens. If symptoms of hypoglycemia appear, immediate intake of sugars is necessary, and it is advisable to always have preparations for sugar intake ready at hand. Furthermore, during stressful situations or surgery, infections, etc., blood sugar control may become difficult and insulin therapy may be considered. When taking this medication with others, there is a potential for interactions hence patients should inform their doctors or pharmacists of any currently taken medications, especially when taking specific antibiotics, antifungals, beta-blockers, and corticosteroids. Pregnant or breastfeeding women are advised not to use this medication and should consider switching to insulin therapy if necessary. Safety and efficacy in children under 18 years have not been established, hence it is recommended not to use in this age group. Elderly patients may have reduced kidney function, necessitating caution in dose adjustments. In cases of overdose, the risk of hypoglycemia is significantly elevated, requiring immediate emergency treatment, and intravenous glucose may be required if necessary. This medication should be kept out of reach of children and should be stored in its original container to maintain the quality of the drug.

Side effects

  • Hypoglycemia
  • headache
  • severe hunger
  • nausea
  • vomiting
  • fatigue
  • sleep
  • sleep disturbances
  • anxiety
  • aggression
Show 68 more
  • decreased concentration
  • decreased agility or activity
  • depression
  • confusion
  • speech abnormalities
  • aphasia
  • visual impairment
  • tremor
  • incomplete paralysis
  • sensory disturbances
  • dizziness
  • weakness
  • loss of self-control
  • transient mental confusion
  • seizures
  • drowsiness
  • loss of consciousness
  • coma
  • shallow breathing
  • bradycardia
  • sweating
  • cold and clammy skin
  • tachycardia
  • hypertension
  • palpitations
  • angina
  • venous arrhythmia
  • blurred vision
  • a sense of fullness in the upper abdomen
  • pressure
  • abdominal pain
  • diarrhea
  • increased liver enzymes
  • liver dysfunction
  • bile secretion disorder
  • jaundice
  • hepatitis
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • anemia
  • granulocytopenia
  • agranulocytosis
  • pancytopenia
  • itching
  • urticaria
  • rash
  • dyspnea
  • hypotension
  • shock
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • allergic vasculitis
  • photosensitivity reaction of the skin
  • decreased serum sodium concentration
  • taste disorder
  • hair loss
  • weight gain
  • dizziness
  • liver dysfunction
  • abdominal pain
  • joint pain
  • dyspepsia
  • facial edema
  • erectile dysfunction
  • facial flushing
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air or moisture, so it should be stored in a sealed container. It is also advisable to keep it at room temperature between 1 and 30 degrees Celsius. By doing so, the drug's effectiveness can be well maintained.

Appearance and packaging

Appearance

Green oblong tablet

Package unit

30 tablets/bottle, 200 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.